2024-03-29T06:03:21Zhttp://digital.csic.es/dspace-oai/requestoai:digital.csic.es:10261/1753342020-07-03T11:27:23Zcom_10261_5063com_10261_5col_10261_5081
2019-02-06T08:17:19Z
urn:hdl:10261/175334
Fatty acid amides for the prevention and/or treatment of steatohepatitis
Rodríguez de Fonseca, Fernando
Pavón Morón, Francico Javier
Serrano Criado, Antonia
Decara del Olmo, Juan Manuel
Joglar Tamargo, Jesús
Clapés Saborit, Pere
Torre, Rafael de la
Ferre Albaladejo, Magí
Covas, María Isabel
Fitó, Montserrat
Almeida Cotrim, Bruno
The invention relates to the use of fatty acid amides with phenylalkylamines and a pharmaceutical composition comprising at least one of said compounds in the prevention and/or treatment of fatty liver or a pathological condition or disease caused by fatty liver, either alcoholic or non-alcoholic, and in particular, for the prevention and/or treatment of alcoholic steatohepatitis or non-alcoholic steatohepatitis (NASH).
2019-02-06T08:17:19Z
2019-02-06T08:17:19Z
2017-10-04
2015-11-24
solicitud de patente
EP3225237 A1
http://hdl.handle.net/10261/175334
158633644
eng
ES2575231 B1 (2016-06-27)
ES2575231 A1 (2016-06-27)
CN107427480 A (2016-06-27)
EP3225237 A4 (2018-12-05)
MX2017006747 A (2018-01-2018)
US2018193293 A1 (2018-07-12)
WO2016083646 A1 (2016-06-02)
Sí
openAccess